More than 10% of fecal immunochemical tests (FIT) used for routine colorectal cancer (CRC) screening in a safety-net health system contained unsatisfactory samples that could not be processed, ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study. Unlike ...

Colorectal cancer is the third most common cancer worldwide, with over 1.9 million new cases in 2020, and is also the third most common cause of cancer-related mortality. 1 Colorectal cancer rates are ...

In DID analysis, the rate of incidence was reduced by 0.34 cases per person-years in the screening group as compared with the historical FIT screening group (rate ratio [RR], 0.08 [95% CI, 0.07 to ...

England’s National Health Service’s faecal immunochemical test (FIT) has reduced referrals for suspected bowel cancer by ...